Investment subsidiary of a Fortune 100 financial institution

January 29, 2010

Representation of the investment subsidiary of a Fortune 100 financial institution as joint lead arranger and joint book manager of $220 million secured revolving credit and term loan facilities provided to a leading provider of integrated anatomic pathology and oncology testing services.
Back to top